nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP3A4—bone cancer	0.494	1	CbGaD
Amitriptyline—HTR1B—dura mater—bone cancer	0.015	0.147	CbGeAlD
Amitriptyline—HTR1D—dura mater—bone cancer	0.0145	0.142	CbGeAlD
Amitriptyline—CYP2B6—Cisplatin—bone cancer	0.0141	0.22	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—bone cancer	0.00947	0.147	CbGbCtD
Amitriptyline—ALB—Methotrexate—bone cancer	0.00899	0.14	CbGbCtD
Amitriptyline—CYP2C9—Cisplatin—bone cancer	0.00747	0.116	CbGbCtD
Amitriptyline—ABCB1—Cisplatin—bone cancer	0.00724	0.113	CbGbCtD
Amitriptyline—HTR1B—trigeminal nerve—bone cancer	0.00645	0.0632	CbGeAlD
Amitriptyline—HTR1D—trigeminal nerve—bone cancer	0.00624	0.0612	CbGeAlD
Amitriptyline—ABCB1—Doxorubicin—bone cancer	0.00486	0.0754	CbGbCtD
Amitriptyline—ORM1—vertebral column—bone cancer	0.00481	0.0471	CbGeAlD
Amitriptyline—HRH1—nose—bone cancer	0.00473	0.0464	CbGeAlD
Amitriptyline—ABCB1—Methotrexate—bone cancer	0.0047	0.0731	CbGbCtD
Amitriptyline—HTR1B—cranial nerve—bone cancer	0.0046	0.0451	CbGeAlD
Amitriptyline—CYP2D6—Doxorubicin—bone cancer	0.00457	0.0711	CbGbCtD
Amitriptyline—HTR1D—cranial nerve—bone cancer	0.00445	0.0436	CbGeAlD
Amitriptyline—Paresthesia of limbs—Methotrexate—bone cancer	0.00393	0.0388	CcSEcCtD
Amitriptyline—HTR7—cranial nerve—bone cancer	0.00354	0.0347	CbGeAlD
Amitriptyline—NTRK2—connective tissue—bone cancer	0.0032	0.0314	CbGeAlD
Amitriptyline—HTR2A—trigeminal nerve—bone cancer	0.0031	0.0304	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—bone cancer	0.00291	0.0452	CbGbCtD
Amitriptyline—Inappropriate antidiuretic hormone secretion—Cisplatin—bone cancer	0.00236	0.0233	CcSEcCtD
Amitriptyline—HRH4—bone marrow—bone cancer	0.00228	0.0224	CbGeAlD
Amitriptyline—HTR2A—cranial nerve—bone cancer	0.00221	0.0217	CbGeAlD
Amitriptyline—HTR2A—vertebral column—bone cancer	0.00217	0.0212	CbGeAlD
Amitriptyline—NTRK2—bone marrow—bone cancer	0.00213	0.0209	CbGeAlD
Amitriptyline—NTRK2—spinal cord—bone cancer	0.00212	0.0208	CbGeAlD
Amitriptyline—HTR2A—hindlimb—bone cancer	0.00186	0.0183	CbGeAlD
Amitriptyline—Ageusia—Cisplatin—bone cancer	0.00169	0.0167	CcSEcCtD
Amitriptyline—HTR2A—appendage—bone cancer	0.0016	0.0157	CbGeAlD
Amitriptyline—Dysarthria—Cisplatin—bone cancer	0.00145	0.0143	CcSEcCtD
Amitriptyline—KCND2—spinal cord—bone cancer	0.0014	0.0138	CbGeAlD
Amitriptyline—Bundle branch block—Epirubicin—bone cancer	0.0014	0.0138	CcSEcCtD
Amitriptyline—Cardiomyopathy—Epirubicin—bone cancer	0.00138	0.0136	CcSEcCtD
Amitriptyline—Body temperature increased—Carboplatin—bone cancer	0.00132	0.013	CcSEcCtD
Amitriptyline—Bundle branch block—Doxorubicin—bone cancer	0.00129	0.0127	CcSEcCtD
Amitriptyline—KCNA1—tendon—bone cancer	0.00128	0.0125	CbGeAlD
Amitriptyline—Cardiomyopathy—Doxorubicin—bone cancer	0.00127	0.0126	CcSEcCtD
Amitriptyline—KCNA1—spinal cord—bone cancer	0.00123	0.0121	CbGeAlD
Amitriptyline—Azatadine—CYP3A4—bone cancer	0.00112	0.135	CrCbGaD
Amitriptyline—Bone marrow depression—Methotrexate—bone cancer	0.00112	0.011	CcSEcCtD
Amitriptyline—Clomipramine—GSTP1—bone cancer	0.00106	0.128	CrCbGaD
Amitriptyline—Bone marrow depression—Epirubicin—bone cancer	0.00104	0.0103	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Cisplatin—bone cancer	0.00102	0.01	CcSEcCtD
Amitriptyline—Bone marrow depression—Doxorubicin—bone cancer	0.000966	0.00953	CcSEcCtD
Amitriptyline—Irritability—Cisplatin—bone cancer	0.000951	0.00938	CcSEcCtD
Amitriptyline—HTR1D—connective tissue—bone cancer	0.000918	0.009	CbGeAlD
Amitriptyline—Orthostatic hypotension—Cisplatin—bone cancer	0.00091	0.00898	CcSEcCtD
Amitriptyline—Ageusia—Epirubicin—bone cancer	0.00087	0.00858	CcSEcCtD
Amitriptyline—Sweating increased—Cisplatin—bone cancer	0.000839	0.00828	CcSEcCtD
Amitriptyline—Pancytopenia—Cisplatin—bone cancer	0.000818	0.00807	CcSEcCtD
Amitriptyline—Ageusia—Doxorubicin—bone cancer	0.000805	0.00794	CcSEcCtD
Amitriptyline—Dysarthria—Methotrexate—bone cancer	0.000796	0.00786	CcSEcCtD
Amitriptyline—Olopatadine—CYP3A4—bone cancer	0.000779	0.0935	CrCbGaD
Amitriptyline—Acute coronary syndrome—Cisplatin—bone cancer	0.000757	0.00747	CcSEcCtD
Amitriptyline—Myocardial infarction—Cisplatin—bone cancer	0.000753	0.00742	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Cisplatin—bone cancer	0.000753	0.00742	CcSEcCtD
Amitriptyline—Dyskinesia—Epirubicin—bone cancer	0.00075	0.0074	CcSEcCtD
Amitriptyline—Stomatitis—Cisplatin—bone cancer	0.000749	0.00738	CcSEcCtD
Amitriptyline—Dysarthria—Epirubicin—bone cancer	0.000745	0.00735	CcSEcCtD
Amitriptyline—HTR7—connective tissue—bone cancer	0.000731	0.00717	CbGeAlD
Amitriptyline—Atrioventricular block—Epirubicin—bone cancer	0.000727	0.00717	CcSEcCtD
Amitriptyline—Coordination abnormal—Epirubicin—bone cancer	0.000718	0.00708	CcSEcCtD
Amitriptyline—Alimemazine—CYP3A4—bone cancer	0.000711	0.0853	CrCbGaD
Amitriptyline—Ventricular tachycardia—Epirubicin—bone cancer	0.000705	0.00695	CcSEcCtD
Amitriptyline—Dyskinesia—Doxorubicin—bone cancer	0.000694	0.00685	CcSEcCtD
Amitriptyline—Dysarthria—Doxorubicin—bone cancer	0.00069	0.0068	CcSEcCtD
Amitriptyline—Coma—Methotrexate—bone cancer	0.000688	0.00679	CcSEcCtD
Amitriptyline—OPRM1—spinal cord—bone cancer	0.000687	0.00673	CbGeAlD
Amitriptyline—Gynaecomastia—Methotrexate—bone cancer	0.000674	0.00665	CcSEcCtD
Amitriptyline—ORM1—bone marrow—bone cancer	0.000673	0.0066	CbGeAlD
Amitriptyline—Atrioventricular block—Doxorubicin—bone cancer	0.000672	0.00663	CcSEcCtD
Amitriptyline—ORM1—spinal cord—bone cancer	0.00067	0.00657	CbGeAlD
Amitriptyline—Coordination abnormal—Doxorubicin—bone cancer	0.000664	0.00655	CcSEcCtD
Amitriptyline—Cyclobenzaprine—CYP3A4—bone cancer	0.000655	0.0786	CrCbGaD
Amitriptyline—Ventricular tachycardia—Doxorubicin—bone cancer	0.000652	0.00643	CcSEcCtD
Amitriptyline—Epinastine—CYP3A4—bone cancer	0.00065	0.078	CrCbGaD
Amitriptyline—Coma—Epirubicin—bone cancer	0.000644	0.00635	CcSEcCtD
Amitriptyline—Tinnitus—Cisplatin—bone cancer	0.000643	0.00634	CcSEcCtD
Amitriptyline—HTR1B—spinal cord—bone cancer	0.000629	0.00616	CbGeAlD
Amitriptyline—Arrhythmia—Cisplatin—bone cancer	0.000616	0.00607	CcSEcCtD
Amitriptyline—Mental disability—Epirubicin—bone cancer	0.000612	0.00603	CcSEcCtD
Amitriptyline—Alopecia—Cisplatin—bone cancer	0.000609	0.00601	CcSEcCtD
Amitriptyline—Hepatic failure—Methotrexate—bone cancer	0.000608	0.006	CcSEcCtD
Amitriptyline—HTR2C—spinal cord—bone cancer	0.000603	0.00591	CbGeAlD
Amitriptyline—Oxcarbazepine—CYP3A4—bone cancer	0.000599	0.0719	CrCbGaD
Amitriptyline—Coma—Doxorubicin—bone cancer	0.000596	0.00588	CcSEcCtD
Amitriptyline—SIGMAR1—tendon—bone cancer	0.000588	0.00577	CbGeAlD
Amitriptyline—Vascular purpura—Epirubicin—bone cancer	0.000572	0.00564	CcSEcCtD
Amitriptyline—SLC6A4—spinal cord—bone cancer	0.000571	0.0056	CbGeAlD
Amitriptyline—SIGMAR1—bone marrow—bone cancer	0.00057	0.00559	CbGeAlD
Amitriptyline—Hepatic failure—Epirubicin—bone cancer	0.000569	0.00562	CcSEcCtD
Amitriptyline—SIGMAR1—spinal cord—bone cancer	0.000567	0.00556	CbGeAlD
Amitriptyline—Mental disability—Doxorubicin—bone cancer	0.000566	0.00558	CcSEcCtD
Amitriptyline—Vision blurred—Cisplatin—bone cancer	0.000566	0.00558	CcSEcCtD
Amitriptyline—Tremor—Cisplatin—bone cancer	0.000562	0.00555	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Methotrexate—bone cancer	0.000558	0.0055	CcSEcCtD
Amitriptyline—Ill-defined disorder—Cisplatin—bone cancer	0.000557	0.00549	CcSEcCtD
Amitriptyline—Osteoarthritis—Methotrexate—bone cancer	0.000547	0.00539	CcSEcCtD
Amitriptyline—HRH1—connective tissue—bone cancer	0.000546	0.00535	CbGeAlD
Amitriptyline—Malaise—Cisplatin—bone cancer	0.000541	0.00534	CcSEcCtD
Amitriptyline—Leukopenia—Cisplatin—bone cancer	0.000537	0.0053	CcSEcCtD
Amitriptyline—ADRA2A—connective tissue—bone cancer	0.000536	0.00526	CbGeAlD
Amitriptyline—Purpura—Epirubicin—bone cancer	0.000531	0.00524	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—bone cancer	0.000529	0.00522	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—bone cancer	0.000527	0.0052	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Epirubicin—bone cancer	0.000522	0.00515	CcSEcCtD
Amitriptyline—Irritability—Methotrexate—bone cancer	0.000522	0.00515	CcSEcCtD
Amitriptyline—Convulsion—Cisplatin—bone cancer	0.00052	0.00513	CcSEcCtD
Amitriptyline—Ataxia—Methotrexate—bone cancer	0.000514	0.00507	CcSEcCtD
Amitriptyline—Osteoarthritis—Epirubicin—bone cancer	0.000512	0.00505	CcSEcCtD
Amitriptyline—Anxiety—Cisplatin—bone cancer	0.000509	0.00502	CcSEcCtD
Amitriptyline—HTR1A—spinal cord—bone cancer	0.000507	0.00497	CbGeAlD
Amitriptyline—Discomfort—Cisplatin—bone cancer	0.000505	0.00498	CcSEcCtD
Amitriptyline—HTR7—tendon—bone cancer	0.000503	0.00493	CbGeAlD
Amitriptyline—Purpura—Doxorubicin—bone cancer	0.000491	0.00485	CcSEcCtD
Amitriptyline—Oedema—Cisplatin—bone cancer	0.00049	0.00483	CcSEcCtD
Amitriptyline—HTR7—spinal cord—bone cancer	0.000485	0.00475	CbGeAlD
Amitriptyline—Cerebrovascular accident—Doxorubicin—bone cancer	0.000483	0.00477	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—bone cancer	0.000481	0.00475	CcSEcCtD
Amitriptyline—Thrombocytopenia—Cisplatin—bone cancer	0.00048	0.00473	CcSEcCtD
Amitriptyline—Tachycardia—Cisplatin—bone cancer	0.000478	0.00471	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—bone cancer	0.000474	0.00467	CcSEcCtD
Amitriptyline—Hyperhidrosis—Cisplatin—bone cancer	0.000473	0.00467	CcSEcCtD
Amitriptyline—Eosinophilia—Methotrexate—bone cancer	0.000468	0.00462	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Epirubicin—bone cancer	0.000467	0.00461	CcSEcCtD
Amitriptyline—Anorexia—Cisplatin—bone cancer	0.000467	0.0046	CcSEcCtD
Amitriptyline—Hypotension—Cisplatin—bone cancer	0.000458	0.00451	CcSEcCtD
Amitriptyline—HTR2A—connective tissue—bone cancer	0.000456	0.00447	CbGeAlD
Amitriptyline—Pancytopenia—Methotrexate—bone cancer	0.000449	0.00443	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—bone cancer	0.000445	0.00439	CcSEcCtD
Amitriptyline—Paraesthesia—Cisplatin—bone cancer	0.00044	0.00434	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—bone cancer	0.000438	0.00432	CcSEcCtD
Amitriptyline—Erectile dysfunction—Methotrexate—bone cancer	0.000435	0.00429	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—bone cancer	0.000432	0.00427	CcSEcCtD
Amitriptyline—Decreased appetite—Cisplatin—bone cancer	0.000426	0.0042	CcSEcCtD
Amitriptyline—Drowsiness—Methotrexate—bone cancer	0.000421	0.00416	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—bone cancer	0.00042	0.00414	CcSEcCtD
Amitriptyline—Stomatitis—Methotrexate—bone cancer	0.000411	0.00405	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—bone cancer	0.000409	0.00403	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—bone cancer	0.000405	0.004	CcSEcCtD
Amitriptyline—Feeling abnormal—Cisplatin—bone cancer	0.000404	0.00398	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—bone cancer	0.000403	0.00397	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—bone cancer	0.000394	0.00389	CcSEcCtD
Amitriptyline—Agranulocytosis—Methotrexate—bone cancer	0.000393	0.00388	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—bone cancer	0.000389	0.00383	CcSEcCtD
Amitriptyline—Body temperature increased—Cisplatin—bone cancer	0.000387	0.00382	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—bone cancer	0.000387	0.00381	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—bone cancer	0.000384	0.00379	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—bone cancer	0.000384	0.00379	CcSEcCtD
Amitriptyline—Hepatitis—Methotrexate—bone cancer	0.000378	0.00373	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—bone cancer	0.000378	0.00373	CcSEcCtD
Amitriptyline—Mianserin—CYP3A4—bone cancer	0.000376	0.0451	CrCbGaD
Amitriptyline—HRH1—tendon—bone cancer	0.000375	0.00368	CbGeAlD
Amitriptyline—Weight increased—Doxorubicin—bone cancer	0.000372	0.00367	CcSEcCtD
Amitriptyline—ADRA2A—tendon—bone cancer	0.000369	0.00361	CbGeAlD
Amitriptyline—Agranulocytosis—Epirubicin—bone cancer	0.000368	0.00363	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—bone cancer	0.000365	0.0036	CcSEcCtD
Amitriptyline—CYP2E1—tendon—bone cancer	0.000361	0.00354	CbGeAlD
Amitriptyline—Neuropathy peripheral—Doxorubicin—bone cancer	0.000358	0.00353	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—bone cancer	0.000356	0.00351	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—bone cancer	0.000356	0.00351	CcSEcCtD
Amitriptyline—ADRA2A—spinal cord—bone cancer	0.000356	0.00349	CbGeAlD
Amitriptyline—Hepatitis—Epirubicin—bone cancer	0.000354	0.00349	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—bone cancer	0.000353	0.00348	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—bone cancer	0.000352	0.00347	CcSEcCtD
Amitriptyline—Asthenia—Cisplatin—bone cancer	0.000351	0.00347	CcSEcCtD
Amitriptyline—CYP2E1—spinal cord—bone cancer	0.000348	0.00341	CbGeAlD
Amitriptyline—Clomipramine—CYP3A4—bone cancer	0.000344	0.0413	CrCbGaD
Amitriptyline—Agranulocytosis—Doxorubicin—bone cancer	0.000341	0.00336	CcSEcCtD
Amitriptyline—Nortriptyline—CYP3A4—bone cancer	0.000336	0.0404	CrCbGaD
Amitriptyline—Diarrhoea—Cisplatin—bone cancer	0.000335	0.00331	CcSEcCtD
Amitriptyline—Alopecia—Methotrexate—bone cancer	0.000334	0.0033	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—bone cancer	0.00033	0.00326	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—bone cancer	0.000328	0.00323	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—bone cancer	0.000326	0.00321	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—bone cancer	0.000322	0.00318	CcSEcCtD
Amitriptyline—Trimipramine—CYP3A4—bone cancer	0.000316	0.038	CrCbGaD
Amitriptyline—Arrhythmia—Epirubicin—bone cancer	0.000316	0.00312	CcSEcCtD
Amitriptyline—HTR2A—tendon—bone cancer	0.000313	0.00307	CbGeAlD
Amitriptyline—Alopecia—Epirubicin—bone cancer	0.000313	0.00309	CcSEcCtD
Amitriptyline—Vomiting—Cisplatin—bone cancer	0.000311	0.00307	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—bone cancer	0.00031	0.00306	CcSEcCtD
Amitriptyline—Rash—Cisplatin—bone cancer	0.000309	0.00305	CcSEcCtD
Amitriptyline—Dermatitis—Cisplatin—bone cancer	0.000309	0.00304	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—bone cancer	0.000306	0.00301	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—bone cancer	0.000305	0.00301	CcSEcCtD
Amitriptyline—HTR2A—spinal cord—bone cancer	0.000302	0.00296	CbGeAlD
Amitriptyline—Dysgeusia—Epirubicin—bone cancer	0.000302	0.00298	CcSEcCtD
Amitriptyline—Doxepin—CYP3A4—bone cancer	0.000302	0.0362	CrCbGaD
Amitriptyline—Malaise—Methotrexate—bone cancer	0.000297	0.00293	CcSEcCtD
Amitriptyline—Leukopenia—Methotrexate—bone cancer	0.000295	0.00291	CcSEcCtD
Amitriptyline—Orphenadrine—CYP3A4—bone cancer	0.000294	0.0353	CrCbGaD
Amitriptyline—Arrhythmia—Doxorubicin—bone cancer	0.000293	0.00289	CcSEcCtD
Amitriptyline—Nausea—Cisplatin—bone cancer	0.000291	0.00287	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—bone cancer	0.00029	0.00286	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—bone cancer	0.000289	0.00286	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—bone cancer	0.000286	0.00282	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—bone cancer	0.000285	0.00281	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—bone cancer	0.000283	0.00279	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—bone cancer	0.000279	0.00275	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—bone cancer	0.000278	0.00274	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—bone cancer	0.000277	0.00273	CcSEcCtD
Amitriptyline—Desipramine—CYP3A4—bone cancer	0.000277	0.0332	CrCbGaD
Amitriptyline—Syncope—Epirubicin—bone cancer	0.000276	0.00273	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—bone cancer	0.000276	0.00272	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—bone cancer	0.000272	0.00269	CcSEcCtD
Amitriptyline—Confusional state—Methotrexate—bone cancer	0.000271	0.00267	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—bone cancer	0.000271	0.00267	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—bone cancer	0.000269	0.00265	CcSEcCtD
Amitriptyline—Promazine—CYP3A4—bone cancer	0.000268	0.0322	CrCbGaD
Amitriptyline—Convulsion—Epirubicin—bone cancer	0.000267	0.00263	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—bone cancer	0.000266	0.00262	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—bone cancer	0.000265	0.00261	CcSEcCtD
Amitriptyline—Thrombocytopenia—Methotrexate—bone cancer	0.000263	0.0026	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—bone cancer	0.000262	0.00258	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—bone cancer	0.000261	0.00258	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—bone cancer	0.00026	0.00256	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—bone cancer	0.000259	0.00256	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—bone cancer	0.000257	0.00254	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—bone cancer	0.000257	0.00253	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—bone cancer	0.000256	0.00253	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—bone cancer	0.000256	0.00252	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—bone cancer	0.000255	0.00252	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—bone cancer	0.000254	0.0025	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—bone cancer	0.000252	0.00249	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—bone cancer	0.000252	0.00248	CcSEcCtD
Amitriptyline—Hypotension—Methotrexate—bone cancer	0.000251	0.00248	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—bone cancer	0.000251	0.00247	CcSEcCtD
Amitriptyline—Shock—Epirubicin—bone cancer	0.000247	0.00244	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—bone cancer	0.000247	0.00244	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—bone cancer	0.000246	0.00243	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—bone cancer	0.000246	0.00243	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—bone cancer	0.000245	0.00242	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—bone cancer	0.000243	0.0024	CcSEcCtD
Amitriptyline—Insomnia—Methotrexate—bone cancer	0.000243	0.0024	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—bone cancer	0.000242	0.00239	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—bone cancer	0.000241	0.00238	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—bone cancer	0.00024	0.00237	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—bone cancer	0.00024	0.00236	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—bone cancer	0.000239	0.00236	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—bone cancer	0.000237	0.00234	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—bone cancer	0.000237	0.00233	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—bone cancer	0.000235	0.00232	CcSEcCtD
Amitriptyline—Imipramine—CYP3A4—bone cancer	0.000235	0.0282	CrCbGaD
Amitriptyline—Confusional state—Doxorubicin—bone cancer	0.000235	0.00231	CcSEcCtD
Amitriptyline—Decreased appetite—Methotrexate—bone cancer	0.000234	0.0023	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—bone cancer	0.000233	0.0023	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—bone cancer	0.000232	0.00229	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—bone cancer	0.000229	0.00226	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—bone cancer	0.000228	0.00225	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—bone cancer	0.000227	0.00224	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—bone cancer	0.000227	0.00224	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—bone cancer	0.000226	0.00223	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—bone cancer	0.000225	0.00222	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—bone cancer	0.000224	0.00221	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—bone cancer	0.000222	0.00219	CcSEcCtD
Amitriptyline—Feeling abnormal—Methotrexate—bone cancer	0.000221	0.00218	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—bone cancer	0.000221	0.00218	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—bone cancer	0.000219	0.00216	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—bone cancer	0.000217	0.00214	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—bone cancer	0.000217	0.00214	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—bone cancer	0.000215	0.00212	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—bone cancer	0.000214	0.00211	CcSEcCtD
Amitriptyline—Body temperature increased—Methotrexate—bone cancer	0.000212	0.0021	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—bone cancer	0.00021	0.00208	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—bone cancer	0.000209	0.00206	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—bone cancer	0.000207	0.00204	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—bone cancer	0.000207	0.00204	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—bone cancer	0.000205	0.00202	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—bone cancer	0.000202	0.002	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—bone cancer	0.000201	0.00198	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—bone cancer	0.0002	0.00197	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—bone cancer	0.000199	0.00196	CcSEcCtD
Amitriptyline—ABCB1—bone marrow—bone cancer	0.000199	0.00195	CbGeAlD
Amitriptyline—Body temperature increased—Epirubicin—bone cancer	0.000199	0.00196	CcSEcCtD
Amitriptyline—ABCB1—spinal cord—bone cancer	0.000198	0.00194	CbGeAlD
Amitriptyline—Asthenia—Methotrexate—bone cancer	0.000193	0.0019	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—bone cancer	0.000192	0.00189	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—bone cancer	0.00019	0.00188	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—bone cancer	0.000185	0.00182	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—bone cancer	0.000184	0.00181	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—bone cancer	0.000184	0.00181	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—bone cancer	0.00018	0.00178	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—bone cancer	0.000178	0.00176	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—bone cancer	0.000178	0.00175	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—bone cancer	0.000172	0.0017	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—bone cancer	0.000171	0.00169	CcSEcCtD
Amitriptyline—Rash—Methotrexate—bone cancer	0.000169	0.00167	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—bone cancer	0.000169	0.00167	CcSEcCtD
Amitriptyline—Headache—Methotrexate—bone cancer	0.000168	0.00166	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—bone cancer	0.000167	0.00165	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—bone cancer	0.000166	0.00164	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—bone cancer	0.000165	0.00162	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—bone cancer	0.00016	0.00158	CcSEcCtD
Amitriptyline—Nausea—Methotrexate—bone cancer	0.00016	0.00157	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—bone cancer	0.000159	0.00157	CcSEcCtD
Amitriptyline—Rash—Epirubicin—bone cancer	0.000159	0.00156	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—bone cancer	0.000158	0.00156	CcSEcCtD
Amitriptyline—Headache—Epirubicin—bone cancer	0.000158	0.00155	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—bone cancer	0.000154	0.00152	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—bone cancer	0.000149	0.00147	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—bone cancer	0.000148	0.00146	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—bone cancer	0.000147	0.00145	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—bone cancer	0.000147	0.00145	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—bone cancer	0.000146	0.00144	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—bone cancer	0.000138	0.00136	CcSEcCtD
Amitriptyline—ADRA2A—Signaling Pathways—IL3—bone cancer	2.12e-05	9.22e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—DHFR—bone cancer	2.12e-05	9.22e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—KIT—bone cancer	2.11e-05	9.17e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ENO2—bone cancer	2.1e-05	9.14e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ENO2—bone cancer	2.09e-05	9.06e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—DHFR—bone cancer	2.07e-05	9e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.07e-05	8.99e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—KIT—bone cancer	2.07e-05	8.98e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—GSTP1—bone cancer	2.03e-05	8.84e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—BRAF—bone cancer	2.03e-05	8.82e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.03e-05	8.81e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—CYP3A4—bone cancer	2.01e-05	8.75e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—KIT—bone cancer	2.01e-05	8.72e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2e-05	8.7e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—CYP3A4—bone cancer	2e-05	8.7e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—BRAF—bone cancer	2e-05	8.69e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—BRAF—bone cancer	2e-05	8.68e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.99e-05	8.66e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—GSTP1—bone cancer	1.99e-05	8.66e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.99e-05	8.65e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.99e-05	8.65e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—GSTP1—bone cancer	1.99e-05	8.64e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—BRAF—bone cancer	1.99e-05	8.62e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFBR2—bone cancer	1.98e-05	8.62e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GNA11—bone cancer	1.98e-05	8.61e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFBR2—bone cancer	1.98e-05	8.59e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—EGFR—bone cancer	1.97e-05	8.55e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFBR2—bone cancer	1.96e-05	8.51e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.95e-05	8.48e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—DHFR—bone cancer	1.95e-05	8.48e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—BRAF—bone cancer	1.94e-05	8.44e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MDM2—bone cancer	1.94e-05	8.43e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—EGFR—bone cancer	1.94e-05	8.42e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—EGFR—bone cancer	1.94e-05	8.41e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GNA11—bone cancer	1.94e-05	8.41e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—DHFR—bone cancer	1.93e-05	8.4e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—EGFR—bone cancer	1.93e-05	8.37e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.92e-05	8.36e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KIT—bone cancer	1.92e-05	8.35e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IGF1R—bone cancer	1.91e-05	8.28e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—JUN—bone cancer	1.9e-05	8.25e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—BRAF—bone cancer	1.89e-05	8.2e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.88e-05	8.18e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.88e-05	8.15e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IGF1R—bone cancer	1.87e-05	8.13e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IGF1R—bone cancer	1.87e-05	8.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IGF1R—bone cancer	1.86e-05	8.08e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—MMP9—bone cancer	1.85e-05	8.03e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IGF1R—bone cancer	1.84e-05	8e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.84e-05	7.98e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—EGFR—bone cancer	1.83e-05	7.95e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KIT—bone cancer	1.83e-05	7.93e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GNA11—bone cancer	1.82e-05	7.92e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.81e-05	7.88e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GNA11—bone cancer	1.81e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KIT—bone cancer	1.81e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KIT—bone cancer	1.81e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—BRAF—bone cancer	1.81e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CYP3A4—bone cancer	1.8e-05	7.81e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.79e-05	7.77e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ENO2—bone cancer	1.78e-05	7.74e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CYP3A4—bone cancer	1.75e-05	7.62e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—EGFR—bone cancer	1.75e-05	7.62e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—EGFR—bone cancer	1.75e-05	7.61e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GSTP1—bone cancer	1.72e-05	7.48e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—BRAF—bone cancer	1.72e-05	7.45e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GSTP1—bone cancer	1.71e-05	7.44e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.71e-05	7.42e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MDM2—bone cancer	1.7e-05	7.39e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—BRAF—bone cancer	1.7e-05	7.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.7e-05	7.38e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—JUN—bone cancer	1.69e-05	7.32e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MDM2—bone cancer	1.68e-05	7.28e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MDM2—bone cancer	1.67e-05	7.27e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MDM2—bone cancer	1.66e-05	7.23e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—EGFR—bone cancer	1.66e-05	7.22e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CYP3A4—bone cancer	1.65e-05	7.18e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—DHFR—bone cancer	1.65e-05	7.18e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—TP53—bone cancer	1.65e-05	7.17e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—EGFR—bone cancer	1.65e-05	7.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.65e-05	7.15e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MMP9—bone cancer	1.64e-05	7.13e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CYP3A4—bone cancer	1.64e-05	7.12e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.63e-05	7.08e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MDM2—bone cancer	1.63e-05	7.08e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—TP53—bone cancer	1.62e-05	7.03e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MDM2—bone cancer	1.58e-05	6.87e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KIT—bone cancer	1.58e-05	6.84e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KIT—bone cancer	1.57e-05	6.81e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GNA11—bone cancer	1.54e-05	6.71e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GSTP1—bone cancer	1.54e-05	6.68e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MDM2—bone cancer	1.51e-05	6.58e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GSTP1—bone cancer	1.5e-05	6.52e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KIT—bone cancer	1.5e-05	6.52e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—EGFR—bone cancer	1.49e-05	6.49e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—BRAF—bone cancer	1.48e-05	6.43e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—JUN—bone cancer	1.48e-05	6.42e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—BRAF—bone cancer	1.47e-05	6.4e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—TP53—bone cancer	1.47e-05	6.4e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—JUN—bone cancer	1.46e-05	6.33e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—JUN—bone cancer	1.46e-05	6.32e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—JUN—bone cancer	1.45e-05	6.28e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MMP9—bone cancer	1.44e-05	6.25e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MDM2—bone cancer	1.44e-05	6.24e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.44e-05	6.23e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.43e-05	6.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.42e-05	6.18e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MDM2—bone cancer	1.42e-05	6.18e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MMP9—bone cancer	1.42e-05	6.16e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MMP9—bone cancer	1.42e-05	6.15e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—JUN—bone cancer	1.42e-05	6.15e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GSTP1—bone cancer	1.41e-05	6.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.41e-05	6.13e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MMP9—bone cancer	1.41e-05	6.11e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GSTP1—bone cancer	1.4e-05	6.09e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP3A4—bone cancer	1.4e-05	6.08e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.39e-05	6.05e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KIT—bone cancer	1.38e-05	6.01e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MMP9—bone cancer	1.38e-05	5.98e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ENO2—bone cancer	1.38e-05	5.97e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—JUN—bone cancer	1.37e-05	5.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.37e-05	5.94e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KIT—bone cancer	1.36e-05	5.91e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KIT—bone cancer	1.36e-05	5.9e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KIT—bone cancer	1.35e-05	5.88e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KIT—bone cancer	1.35e-05	5.86e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MMP9—bone cancer	1.34e-05	5.81e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KIT—bone cancer	1.34e-05	5.8e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KIT—bone cancer	1.33e-05	5.79e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—EGFR—bone cancer	1.33e-05	5.76e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—JUN—bone cancer	1.32e-05	5.72e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TP53—bone cancer	1.3e-05	5.66e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—BRAF—bone cancer	1.3e-05	5.65e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MMP9—bone cancer	1.28e-05	5.56e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—BRAF—bone cancer	1.28e-05	5.56e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—BRAF—bone cancer	1.28e-05	5.55e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—DHFR—bone cancer	1.28e-05	5.54e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—BRAF—bone cancer	1.27e-05	5.53e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—BRAF—bone cancer	1.27e-05	5.51e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—EGFR—bone cancer	1.26e-05	5.47e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—BRAF—bone cancer	1.26e-05	5.46e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TP53—bone cancer	1.25e-05	5.45e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.25e-05	5.44e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—JUN—bone cancer	1.25e-05	5.43e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MDM2—bone cancer	1.24e-05	5.39e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.24e-05	5.39e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KIT—bone cancer	1.24e-05	5.38e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—JUN—bone cancer	1.24e-05	5.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—JUN—bone cancer	1.24e-05	5.38e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—EGFR—bone cancer	1.24e-05	5.37e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MDM2—bone cancer	1.23e-05	5.36e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.23e-05	5.36e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.23e-05	5.34e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PTGS2—bone cancer	1.23e-05	5.32e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.22e-05	5.29e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MMP9—bone cancer	1.22e-05	5.28e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.21e-05	5.27e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MMP9—bone cancer	1.2e-05	5.23e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.2e-05	5.23e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GSTP1—bone cancer	1.2e-05	5.2e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GNA11—bone cancer	1.19e-05	5.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.18e-05	5.13e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.16e-05	5.06e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EGFR—bone cancer	1.16e-05	5.05e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EGFR—bone cancer	1.15e-05	4.98e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EGFR—bone cancer	1.14e-05	4.97e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EGFR—bone cancer	1.14e-05	4.94e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.13e-05	4.9e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTGS2—bone cancer	1.12e-05	4.88e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EGFR—bone cancer	1.11e-05	4.83e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—bone cancer	1.11e-05	4.83e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MDM2—bone cancer	1.09e-05	4.73e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EGFR—bone cancer	1.08e-05	4.69e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—JUN—bone cancer	1.08e-05	4.68e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—JUN—bone cancer	1.07e-05	4.66e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MDM2—bone cancer	1.07e-05	4.66e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MDM2—bone cancer	1.07e-05	4.65e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MDM2—bone cancer	1.07e-05	4.63e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MDM2—bone cancer	1.06e-05	4.62e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—bone cancer	1.05e-05	4.58e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MDM2—bone cancer	1.05e-05	4.57e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.05e-05	4.56e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MMP9—bone cancer	1.05e-05	4.56e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MMP9—bone cancer	1.04e-05	4.53e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—bone cancer	1.03e-05	4.49e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—bone cancer	1.03e-05	4.48e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—bone cancer	1.03e-05	4.48e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—JUN—bone cancer	1.03e-05	4.46e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MMP9—bone cancer	9.99e-06	4.34e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—bone cancer	9.82e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—bone cancer	9.76e-06	4.24e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MDM2—bone cancer	9.75e-06	4.24e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—bone cancer	9.73e-06	4.23e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—bone cancer	9.73e-06	4.23e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—bone cancer	9.62e-06	4.18e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—bone cancer	9.61e-06	4.17e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—bone cancer	9.54e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—JUN—bone cancer	9.47e-06	4.11e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—bone cancer	9.34e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—JUN—bone cancer	9.32e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—JUN—bone cancer	9.3e-06	4.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—JUN—bone cancer	9.27e-06	4.03e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTP1—bone cancer	9.25e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—JUN—bone cancer	9.24e-06	4.01e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MMP9—bone cancer	9.21e-06	4e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—JUN—bone cancer	9.15e-06	3.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—JUN—bone cancer	9.12e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—bone cancer	9.07e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—bone cancer	9.06e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—bone cancer	9.04e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—bone cancer	9.02e-06	3.92e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—bone cancer	8.99e-06	3.9e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—bone cancer	8.92e-06	3.88e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—bone cancer	8.9e-06	3.87e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—bone cancer	8.88e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—bone cancer	8.87e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—bone cancer	8.69e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—bone cancer	8.48e-06	3.68e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—JUN—bone cancer	8.48e-06	3.68e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—bone cancer	8.43e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—bone cancer	8.25e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—bone cancer	8.25e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—bone cancer	8.17e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—bone cancer	8.17e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—bone cancer	8.07e-06	3.51e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—bone cancer	7.96e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—bone cancer	7.77e-06	3.38e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—bone cancer	7.44e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—bone cancer	7.33e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—bone cancer	7.32e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—bone cancer	7.31e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—bone cancer	7.29e-06	3.16e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—bone cancer	7.26e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—bone cancer	7.26e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—bone cancer	7.19e-06	3.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—bone cancer	7.17e-06	3.12e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—bone cancer	7.12e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—bone cancer	7.08e-06	3.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—bone cancer	6.78e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—bone cancer	6.66e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—bone cancer	6.25e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—bone cancer	6.21e-06	2.7e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—bone cancer	6.15e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—bone cancer	6.14e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—bone cancer	6.12e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—bone cancer	6.1e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—bone cancer	6.04e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—bone cancer	6.02e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—bone cancer	5.59e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—bone cancer	4.79e-06	2.08e-05	CbGpPWpGaD
